Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?-Reference-Cited by-同舟云学术

Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?

Published:2018-02-15 Issue:7 Volume:36 Page:733-743
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Antoñanzas Fernando^ORCID,Rodríguez-Ibeas Roberto,Juárez-Castelló Carmelo A.

Funder

MINECO

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/article/10.1007/s40273-018-0619-4/fulltext.html

Reference27 articles.

1. Redekop WK, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health. 2013;16:54–9.

2. Antoñanzas F, Juárez-Castelló C, Rodríguez-Ibeas R. Some economics on personalized and predictive medicine. Eur J Health Econ. 2015;16(9):985–94.

3. Annemans L, Redekop K, Payne K. Current methodological issues in the economic assessment of personalized medicine. Value Health. 2013;16(6 Suppl.):S20–6.

4. Sairamesh J, Rossbach M. An economic perspective on personalized medicine. Hugo J. 2013;7(1):1–2.

5. Connor S. Our Drugs Do Not Work On Most Patients. The Independent (London), 13 Dec 2011. http://www.rense.com/general69/glax.htm . Accessed 6 Feb 2018.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Incentives to Develop and to Use Diagnostic Tests a Literature Review;SSRN Electronic Journal;2024

2. Competing with precision: incentives for developing predictive biomarker tests;The Scandinavian Journal of Economics;2023-10-13

3. Incentives to implement personalized medicine under second‐best pricing;Health Economics;2022-08-25

4. Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator;PLOS ONE;2022-04-29

5. Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options;Applied Health Economics and Health Policy;2022-04-04